Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • The problem with sensitivity analysis of somatic variant caller

    Hello!

    I'm working on somatic variant identification from cancer samples. So, I try to simulate Illumina paired-end read with known variants by using VarSim (http://bioinform.github.io/varsim/), which this tools can simulate the human genome with both germline and somatic mutations (use ART tool as a simulator). In addition, I had simulated tumor reads by vary allele frequency in the range of 0.1 - 0.5.

    As this paper "Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers" (DOI: 10.1186/gm495) mentioned about the sensitivity of any somatic variant caller including MuTect, SomaticSniper, VarScan, Strelka, and JointSNVMix. I had followed the command of any tools that they provide in supplement to calling somatic variations. However, the sensitivity is quite low when compare with their reports. The maximum is around 0.9 at allele frequency equal to 0.5 (MuTect) while at allele frequency equal to 0.5 (MuTect) I got the sensitivity just 0.7 (my simulated reads are chr22).

    So, I have no idea that why the results are very different, even I use only chr22 but I think the results shouldn't be much different.

    Additional, I aligned the reads by using bwa-mem then mark duplicates with Picard-tool and realigned, recalibration with GATK

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    09-09-2024, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Today, 06:25 AM
0 responses
13 views
0 likes
Last Post seqadmin  
Started by seqadmin, Yesterday, 01:02 PM
0 responses
12 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-18-2024, 06:39 AM
0 responses
14 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-11-2024, 02:44 PM
0 responses
14 views
0 likes
Last Post seqadmin  
Working...
X